Protective effects of Gentiana manshurica Kitagawa on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice

Kai-li XIA,Min JIANG,Ben-wen CUI,Yu ZHANG,Jin-hua ZHENG,Yan-ling WU,Ji-xing NAN,Li-hua LIAN
2017-01-01
Abstract:Objective:To investigate the hepatoprotective effects of Gentiana manshurica Kitagawa (GM) on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.Methods:Fulminant hepatic failure mice model were established by i ntraperitoneal injection of D-galactosamine (700mg/kg) and lipopolysaccharide (10μg/kg),GM (50,100,200mg/kg) or legalon (100mg/kg) were given to mice 1 and 12h before modeling.Results:D-galactosamine/lipopolysaccharide led to massive necrosis of hepatocyte,increased serumal level of aminotransferase (AST),alanine aminotransferase (ALT) and tumor necrosis factor (TNF)-α (P<0.01),decreased hepatic glutathione (GSH),superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activation,and increased hepatic lipid hydroperoxide-malonaldehyde (P<0.01).GM intervention significantly ameliorated hepatocyte necrosis,decreased serum level of ALT,AST and TNF-α (P<0.01),increased hepatic GSH,SOD and GSH-Px level (P<0.01),decreased hepatic hydroperoxide-malonaldehyde level (P<0.01),alleviated liver injury and oxidative stress as well.GM could inhibit hepatic DNA fragmentation and cleavage of cysteinyl aspartate specific protease-3 (Caspase-3) remarkably.At the same time,GM pretreatment could suppress hepatic expression of phosphorylated c-jun N-terminal kinase (p-JNK) and phosphorylated extracellular signal regulated kinase (p-ERK).Conclusion:Gentiana manshurica Kitagawa contained hepatoprotective effects on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice through inhibiting hepatocyte apoptosis and suppressing hepatic antioxidant status.
What problem does this paper attempt to address?